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A B S T R A C T
Epilepsy surgery plays a pivotal role in the successful treatments of intractable epilepsy. In China,
economic burden for epileptic patients is heavy. Because of limited economic resources, appropriate
utilization of presurgical evaluation technologies is especially important for low-income patients, who
could beneﬁt from surgery. This study proposed the strategies for restricting the cost of presurgical
evaluation for resective surgery in low-income population with refractory epilepsy. A retrospective
study was performed on the database of patients with resective surgery from January 2007 to June 2009
in West China Hospital of Sichuan University. Presurgical evaluation technologies and outcome were
analyzed. As a result, 143 patients underwent resective operation were included in this study. Seizure
free can be reached at 63.8% patients with (ATL) and 61.1% with focal lesionectomy (FLE). Magnetic
resonance imaging (MRI), magnetic resonance spectroscopy (MRS), positron emission tomography
(PET), routine electroencephalography (REEG), video-EEG (VEEG) and invasive-EEG (IEEG) were used for
investigation. The cost of those technologies was listed for consultation. Based on these ﬁndings, how to
make the proper choice for surgery candidates was suggested according to different types of epilepsy.
 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Epilepsy is one of the most common neurologic diseases, which
affects people from all the ages, genders, ethnic groups and social
levels in the whole world. As is known to all, pharmacal therapy is
the ﬁrst choice for treatment. The effective rate of normative
medication therapy can reach up to 70%, however, approximately
one-third epileptic patients will be drug-resistant. Consequently,
surgery is taken into account by epileptologists. A review found the
median seizure free rate was 56%, and up to 85% patients with
refractory epilepsy can be seizure free postoperatively.1 Rational
pre-operation evaluation, accurate focus localization, eligible
candidate selection and appropriate surgical-style application
are the pivotal factors determining the success of the surgery.
In China, the development of ﬁnance and distribution of
economy are imbalanced among different cities. The economic
burden of epilepsy was incredible heavy for most Chinese people.
Hong et al. reported the family income in second-tier-city of China
ranged ¥200–15,000 ($30–2250) per month; 2% patients had* Corresponding author. Tel.: +86 28 85422791; fax: +86 28 85422490.
** Corresponding author. Tel.: +86 28 85422548; fax: +86 28 85422549.
E-mail addresses: leidickc18@tom.com (D. Lei), zhoudong66@yahoo.de
(D. Zhou).
1059-1311/$ – see front matter  2011 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2011.01.013partial medical cover by insurance, 98% patients had to pay the
whole costs personally.2 Thus, because of unbalanced distribution
of economy and limited insurance coverage, how to restrict
surgery-relative cost and achieve satisfactory surgery-outcome in
low-income population of China is an important issue and crucial
challenge. This paper is proposed to discuss the strategies for the
restriction of surgery-relative costs.
2. Methods
2.1. Data collection
Consecutive patients diagnosed as refractory epilepsy and
underwent epileptic surgery from January 2007 to June 2009 in the
Neurosurgery Department of West China Hospital of Sichuan
University were recruited in this study retrospectively. All the
demographic and clinical data were collected, including age,
gender, presurgical technologies, operative styles and outcome.
According to Engel’s classiﬁcation, four levels were used to assess
the outcome of surgery, and death was also included as another
level of outcome.
The direct costs of surgery and presurgical evaluation methods
derived from the Sichuan province public health administration
tariff. The extra surgery-related cost of physician visits, hospita-
lizations, medications and blood tests were excluded in this study.vier Ltd. All rights reserved.
Table 1
Outcome of different types of surgery and corresponding presurgical evaluation technologies.
n MRI VEEG MRS PET IEEG
ATL (n=47)
I 30 (63.8%) 30 30 8 4 1
II 10 (21.3%) 10 10 1 2 0
III 4 (8.5%) 4 4 1 0 1
IV 2 (4.3%) 2 2 0 0 0
Dead 1 (2.1%)a 1 1 0 0 0
FLE (n=95)
I 58 (61.1%) 58 58 0 1 0
II 11 (11.6%) 11 11 0 3 0
III 13 (13.6%) 13 13 0 0 0
IV 11 (11.6%) 11 11 1 1 0
Dead 2 (2.1%)b 2 2 0 0 0
HE (n=1)
I 1 1 1 0 1 0
ATL, anterior temporal lobectomy; FLE, focal lesionectomy; HE, hemispherectomy; MRI, magnetic resonance imaging; VEEG, video electroencephalography; MRS, magnetic
resonance spectroscopy; PET, positron emission tomography; IEEG, invasive electroencephalography; n, number.
a Because of intracranial hemorrhage.
b Both because of accident.
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Totally, 212 consecutive patients underwent resection opera-
tion for epilepsy. Only 143 patients’ 1–3 years of follow up data
were obtained, 69 patients were lost to follow-up. There were 96
males and 47 females; the mean age was 24.0  10.9 years old,
ranging from 5 to 56 years old; the course of epilepsy ranged from 17
month to 30 years. All the patients took prescribed anti-epileptic
drugs pre- and post-surgery. Presurgical evaluation technologies
included 3T three-dimensional magnetic resonance imaging (3D-
MRI), magnetic resonance spectroscopy (MRS), positron emission
tomography (PET), routine electroencephalography (REEG), video-
EEG (VEEG) and invasive-EEG (IEEG). Each patient had 3D-MRI and
VEEG, most of them had REEG before VEEG test. Single photon
emission computed tomography (SPECT) and functional MRI (fMRI)
are not routinely used for clinical diagnosis. Wada test andMEGwere
unavailable in this hospital.
Anterior temporal lobectomy (ATL), focal lesionectomy (FLE)
and hemispherectomy (HE) were used for resective surgery in our
study. Forty-seven patients had ATL, 95 had FLE and only 1 patient
had HE. The outcome and the technologies used for the presurgical
evaluation of each group are demonstrated in Table 1.
Among patients with FLE, 37 patients had brain cicatrix, most of
which were caused by brain trauma; 25 had tumor; 17 had cystis,
mostly were arachnoid cyst and inﬂammatory cyst; 6 had gray
matter heterotopia; 5 had focal cerebral dysplasia; 3 had
hemangioma; 1 had intracerebral foreign matter; 1 had both gray
matter heterotopia and macrogyria.
The price for different technologies for presurgical evaluation is
shown in Table 2. The average cost for presurgical evaluation is
approximately $480 for ATL, $300 for FLE per patient. Furthermore,
the whole cost of surgery including the evaluation is around
$2550–4230.Table 2
The cost of different surgery-related technologies.
3D-MRIa 3D-MRIb MRS PET
¥ 800 1600 1600 7000
$ 120 240 240 1050
s 87 174 174 760
3D-MRI, three-dimensional magnetic resonance imaging; MRS, magnetic resonance
electroencephalography; REEG, routine electroencephalography; IEEG, invasive electro
a Without contrast.
b With contrast.
c For 24h.
d For half an hour.4. Discussion
Epileptic surgery can be divided into two types: curative and
palliative surgery. Curative surgery is aiming at accurate localiza-
tion of seizure-producing brain tissue and physical resection. The
seizure free rate is 63.2% for temporal lobe resection,3 27–46% for
extratemporal resections,4 and 43–90% for hemispherectomy.5 In
our study, seizure free can be reached at 63.8% patients after ATL
and 61.1% after FLE. The results are similar to previous studies.
In U.S.A., two studies referred to the cost of presurgical
evaluation. One study6 indicated not all the patients underwent
each stage of the evaluation, and the average total cost is $38,500per
patient. Another study found the average cost for evaluation and
operationwas $47,002.7 In European countries, such as Switzerland,
the average cost of inpatient evaluationwas $ 20,846. In developing
countries, the cost was $1200–4262.8,9 In our study, the cost of
surgery including the evaluationwas $2550–4230depending on the
complexity of surgery. Comparing with developed countries,
surgery-related cost is much lower in developing countries.
With the limitation of healthcare, facilities and ﬁnance
resource, especially for low-income population, how to rationally
minimizing the expense of surgery? Our study proposed some
strategies to utilize the limited recourses effectively depending on
different types of surgery.
4.1. Anterior temporal lobectomy (ATL)
Mesial temporal lobe epilepsy (MTLE) is themost common type
of medically intractable partial epilepsy amenable to ATL. MTLE is
characterized by typical clinical semiology, hippocampal sclerosis
found by MRI and unilateral epileptiform waves found by EEG in
temporal lobe. Besides, hypometabolism in temporal lobe can be
demonstrated by PET.VEEGc REEGd IEEG OP
1200 100 8000–10,000 15,000–25,000
180 15 1200–1500 2250–3750
130 11 870–1090 1630–2715
spectroscopy; OP, operation; PET, positron emission tomography; VEEG, video
encephalography; ¥, Renminbi; $, U.S. dollar; s, Euro.
[()TD$FIG]
Refractory epilepsy 
routine EEG MRI
Hippocampal sclerosis 
MTLE 
Suspected cases 
other measurements 
(PET, fMRI, et. al.) 
Undoubted cases 
clinical data 
Epileptic patients 
VEEG 
Undoubted cases Difficult cases 
MTLE 
Further evaluation 
Fig. 1. Flow chat of the stepwise protocol for MTLE.
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surgery can be undoubtedly taken into account. No additional
measurements are needed for validation. This conclusion has also
been proposed by other study.10 A study even indicated MTLE
patientswith consistent unilateral temporal interictal epileptiform
abnormalities may not require VEEG monitoring.11 The ﬂow chart
of the stepwise protocol for the surgical evaluation for MTLE is
represented below (see Fig. 1).
4.2. Focal lesionectomy (FLE)
Primary brain neoplasma, vascular malformation and focal
cortical dysplasia (FCD) are common etiologies for symptomatic
partial seizures. A neuropathological study of 435 Chinese epileptic
patients found the top-three common causes of intractable
epilepsy with lesions were FCD, scar lesions and brain tumors.12
Experience has shown that these lesions, which are detectable in
MRI, are almost always the cause of seizures. When patient has
clear clinical manifestation, consistent EEG and MRI ﬁndings, and
the lesion is unrelated to functional area, operation can be
performed directly without extra investigations.
4.3. Hemispherectomy (HE)
Normally, pharmacoresistant epileptic patients with hemi-
spherical epileptogenic damages, such as Rasmussen’s encephali-
tis, Sturge–Weber syndrome, diffuse cortical malformation,
hemimegalencephaly, and unilateral porencephalic cyst, are
suitable for surgery. Abnormalities can be detected generally
multifocal and widespread throughout the diseased hemisphere
by EEG. MRI is effectual to conﬁrm the impairment. Thus, whenthese patients have thorough unambiguous intractable epilepsy,
accompanying with severe neurological impairment on the
contralateral side, the evidence of neurophysiological (e.g. VEEG)
and radiological (e.g. MRI), HE can be performedwithout extensive
evaluations.5
The stepwise protocol for FLE and HE is similar to the ﬂow chart
of MTLE.
According to the strategies mentioned above, MRI and EEG are
indicated to be the prior measurements, based on which the
resection of epileptogenic-zone can be performed tomany patients
with refractory epilepsy. In our study, the average cost of
presurgical evaluation was limited in approximately $500. Hereby,
with identiﬁed evidence, even without advanced tests, most
patients with refractory epilepsy can be performed surgeries with
minimum surgery-related cost; meanwhile, satisfactory outcome
can be gained as well.
There are still some patients, whose clinical and laboratorial
evidences are inconsistent. In such cases, resective surgery is
always difﬁcult and the long-term outcome is somewhat inferior,
even after cautious evaluation. These cases were barely performed
operation in low-income patients because of multifactorial
consideration.
In addition, skilled staffs for epilepsy service, standard surgical
indications, progressive evaluated technologies and increased
government interventions are still important to improve the
surgical treatment for Chinese epilepsy patients.
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